NORD gratefully acknowledges Seema Lalani, MD, Associate Professor, Department of Molecular and Human Genetics, Baylor College of Medicine, Texas Children’s Hospital; Christina Miyake, MD, MS, Associate Professor – Pediatrics (TCH), Associate Professor – Molecular Physiology and Biophysics (BCM), Baylor College of Medicine, Texas Children’s Hospital; Lindsay Burrage, MD, PhD, Assistant Professor, Department of Molecular and Human Genetics, Baylor College of Medicine, Texas Children’s Hospital, and the TANGO2 Research Foundation, for assistance in the preparation of this report.
TANGO2-related metabolic encephalopathy and arrhythmias is a rare genetic disorder caused by variants in the TANGO2 gene. Affected individuals experience episodes of acute illness called metabolic crises. These episodes can be triggered, often by a preceding infection or from not eating for an extended period of time (fasting). Irregularities in the rhythm of the heart (arrhythmias), the breakdown of muscle tissue (rhabdomyolysis), and other complications can occur during an episode. The term encephalopathy is a general term for brain disease. Neurological problems including intellectual disability and delays in reaching developmental milestones can occur. Additional signs and symptoms can occur both within and outside of metabolic crisis. TANGO2-related metabolic encephalopathy and arrhythmias can affect people very differently. There is no cure for the disorder, but research is underway to better understand and treat this disease. Current treatment is aimed at the specific symptoms present in each individual.
Although researchers have been able to establish a clear syndrome with characteristic or “core” symptoms, much about the disorder is not fully understood. Several factors including the small number of identified cases, the lack of large clinical studies, and the recent discovery of the disorder prevent physicians from developing a complete picture of associated symptoms and prognosis. Parents should talk to their children’s physician and medical team about their specific case, associated symptoms and overall prognosis.
TANGO2-related metabolic encephalopathy and arrhythmias is a variable disorder. This means that how the disorder affects people can vary greatly from one affected individual to another. Therefore, it is important to note that affected individuals may not have all of the symptoms discussed below. Affected individuals can first experience episodes of acute illness called metabolic crisis. Sometimes, affected individuals present with symptoms before a metabolic crisis is apparent. These symptoms can include delays in reaching developmental milestones (developmental delays) and regression, poor coordination, clumsiness, low functioning thyroid gland (hypothyroidism), or seizures.
During a metabolic crisis there can be low blood sugar (hypoglycemia, elevated liver enzymes (transaminitis), elevated creatinine kinase and troponin (enzymes found in skeletal and heart muscle), and a buildup of toxic substances including ammonia (hyperammonemia) and lactic acid in the blood (hyperlactacidemia). A metabolic crisis is often triggered, usually by illness or from not eating for an extended period of time. Stress or dehydration can also trigger an episode. A metabolic crisis may develop rapidly (acutely) and can cause profound muscle weakness, loss of coordination (ataxia), disorientation and, in severe instances, unconsciousness (comatose state).
During a metabolic crisis, some individuals develop a condition called rhabdomyolysis, in which muscle tissue breaks down. Muscle pain (myalgia), muscle weakness, and fatigue can develop. When muscle tissue breaks down, it produces substances that are released into the body including creatinine kinase (CK) and a protein called myoglobulin. Myoglobin can build up in the urine (myoglobinuria). This can cause the urine to appear dark brown. Myoglobinuria can lead to damage of the kidneys. The kidneys have several functions in the body including filtering waste products from the blood. Myoglobulins can cause obstruction of tiny structures in the kidneys called tubules, which damages the kidney. Kidney damage can cause decreased kidney function and eventually kidney failure.
During an acute illness, affected individuals may develop irregular heart rhythms (arrhythmias), abnormalities in the resting electrocardiogram (ECG), and decreased ability for the heart to pump (cardiac dysfunction). All children should have a baseline ECG and echocardiogram which should be repeated during crisis. The most common abnormality during an acute crisis is QT prolongation. Prolongation of the QT interval refers to prolongation of the recovery phase or repolarization of the heart muscle after each heartbeat. Basically, the heart takes longer than normal to recover after each heartbeat. QT prolongation predisposes affected individuals to an increased risk of life-threatening rhythm disturbances, specifically ventricular tachycardia or torsade de pointes. In addition to the QT prolongation, some affected individuals also develop Brugada type I changes in their ECG, which is a specific pattern in the ECG that also predisposes the individuals to ventricular tachycardia and ventricular fibrillation. While QT prolongation appears to persist until the crisis has resolved, Brugada changes can come and go and thus ECGs and telemetry (which is the monitoring of the electrical activity of the heart over an extended period of time) should be monitored throughout the crisis. These arrhythmias can lead to sudden loss of consciousness (syncope), cardiac arrest, and, potentially cause sudden cardiac death.
Arrhythmias that occur during metabolic crisis develop rapidly and can be extremely difficult to manage. Arrhythmias are the leading cause of death among children affected by TANGO2 alterations. In addition to arrhythmias, the heart muscle can develop dysfunction (cardiomyopathy) making it harder to treat the arrhythmias. It is therefore important that all children with TANGO2-related disease be evaluated by an electrophysiologist, who has expertise in heart arrhythmia and cardiomyopathy disorders.
Affected individuals will also have neurodevelopmental problems including intellectual disability, seizures, and problems coordinating voluntary movements (ataxia) causing clumsiness and an unsteady way of walking (unsteady gait) and difficulty with speech (dysarthria). Intellectual disability can range in severity from mild to moderate to severe. Researchers do not know whether intellectual disability is an inherent feature of the disorder itself or whether it develops because of neurological damage that occurs during repeated metabolic crises. Many affected individuals experience developmental delays, or they experience the loss of developmental milestones that they have already reached (regression). In addition, muscle weakness can result in sporadic head tilting and difficulty opening the eyelids and drooling and difficulty swallowing. These episodes are most commonly seen during acute crisis and can come and go within hours.
Some individuals have increased muscle tone in their legs, which can cause muscles to be tight even at rest. Some children are noted to walk on their toes. Some children may have a reduced ability to stretch. Increased muscle tone can lead to spasticity.
Some individuals have low function of the thyroid (hypothyroidism). The thyroid, is a butterfly-shaped gland located at the base of the neck. The thyroid is part of the endocrine system, the network of glands that secrete hormones that regulate the chemical processes (metabolism) that influences the body’s activities such as the heart rate, body temperature, and blood pressure. Hormones are secreted directly into the bloodstream where they travel to various areas of the body. Symptoms of hypothyroidism can include fatigue, dry skin, constipation, increased sensitivity to cold, unintended weight gain, muscle weakness, and hoarseness.
Additional symptoms that have been reported include exaggerated or heightened reflexes (hyperreflexia), and temporary misalignment of the eyes where one or both eyes are turn outward away from the nose (exotropia). In rare instances, affected children have developed sensorineural hearing loss. Sensorineural hearing loss occurs when the nerves within the ear cannot properly send sensory input (sound) to the brain.
TANGO2-related metabolic encephalopathy and arrhythmias is caused by variations in the transport and Golgi organization 2 (TANGO2) gene. Genes provide instructions for creating proteins that play a critical role in many functions of the body. When a mutation of a gene occurs, the protein product may be faulty, inefficient, absent, or overproduced. Depending upon the functions of the particular protein, this can affect many organ systems of the body, including the brain. Researchers are not sure what the protein produced (encoded) by the TANGO2 gene does. It may have a role in secretory protein loading within the endoplasmic reticulum, which is an extensive membrane network found within certain cells where proteins are processed.
The penetrance of disease causing variations in the TANGO2 gene is believed to be 100%. That means everyone who has disease causing changes in both copies of the TANGO2 gene will eventually develop some type of associated sign or symptom of the disorder. Variations in this gene also have variable expressivity, which means the signs and symptoms can differ among affected individuals. Consequently, the severity of the disorder will vary among affected individuals.
Genetic diseases are determined by the combination of genes for a particular trait that are on the chromosomes received from the father and the mother. Disorders inherited in a recessive pattern occur when an individual inherits two variants in a gene for the same trait, one from each parent. If an individual receives one normal gene and one gene for the disease, the person will be a carrier for the disease, but usually will not show symptoms. The risk for two carrier parents to both pass the defective gene and, therefore, have an affected child is 25% with each pregnancy. The risk to have a child who is a carrier like the parents is 50% with each pregnancy. The chance for a child to receive normal genes from both parents and be genetically normal for that particular trait is 25%. The risk is the same for males and females.
TANGO2-related metabolic encephalopathy and arrhythmias is a rare disorder that was first reported in the medical literature in 2016. According to the TANGO2 Research Foundation, as of May 2018, fewer than 30 affected individuals have been identified with the disorder worldwide. Rare diseases often go undiagnosed or misdiagnosed, making it difficult to determine the true frequency in the general population.
A diagnosis of TANGO2-related metabolic encephalopathy and arrhythmias is based upon identification of characteristic symptoms, a detailed patient history, a thorough clinical evaluation and a variety of specialized tests. Diagnostic criteria for this disorder have not yet been established.
Clinical Testing and Workup
Most individuals are diagnosed through molecular genetic testing. Molecular genetic testing can detect a variation in the TANGO2 gene known to cause TANGO2-related metabolic encephalopathy and arrhythmias, but is available only as a diagnostic service at specialized laboratories.
An advanced imaging techniques magnetic resonance imaging (MRI) of the brain may also be performed. An MRI uses a magnetic field and radio waves to produce cross-sectional images of particular organs and bodily tissues, including the brain. Physicians use an MRI to obtain a detailed image of a major region of the brain called the cerebrum. Some affected individuals have shown reduced size of the cerebrum within the skull (cerebral volume loss).
Other tests may be performed to assess specific symptoms. For example, if seizure activity is seen or suspected – body shaking or staring spells, physicians may recommend an electroencephalogram (EEG), which is a test that measures the electrical activity of the brain and may show changes in brain function and help to detect seizures.
The treatment of TANGO2-related metabolic encephalopathy and arrhythmias is directed toward the specific symptoms that are apparent in each individual. Treatment may require the coordinated efforts of a team of specialists. Pediatricians, physicians who specialize in the diagnosis and treatment of metabolic disease in children (pediatric metabolic physicians and geneticists), heart arrhythmias in children (pediatric cardiologists and electrophysiologists), intensive care physicians who specialize in taking care of children in intensive care units, physicians who are experts in the diagnosis and treatment of the brain and central nervous system in children (pediatric neurologists), physicians who specialize in the diagnosis and treatment of hypothyroidism (pediatric endocrinologists), specialists who asses and treat hearing problems (audiologists), and other healthcare professionals may need to systematically and comprehensively plan treatment. Genetic counseling may be of benefit for affected individuals and their families. Psychosocial support for the entire family is essential as well.
There are no standardized treatment protocols or guidelines for affected individuals. Due to the rarity of the disease, there are no treatment trials that have been tested on a large group of patients. Various treatments have been reported in the medical literature as part of single case reports or small series of patients. Treatment trials would be very helpful to determine the long-term safety and effectiveness of specific medications and treatments for individuals with TANGO2-related metabolic encephalopathy and arrhythmias.
A metabolic crisis is a medical emergency that requires prompt treatment. This can include aggressive hydration to treat rhabdomyolysis. Sometimes, sodium bicarbonate-containing fluid may be considered as adjunct therapies. An adjunct therapy is any additional therapy that is used along with the primary treatment option (in this instance aggressive hydration). In some instances, hemodialysis may be necessary if there is severe fluid overload or irregularities with electrolyte balances. Hemodialysis is a procedure in which a machine is used to perform the kidney’s basic functions of fluid and waster removal. Hemodialysis does not remove myoglobin and is not an effective therapy for myoglobin accumulation associated with rhabdomyolysis.
During a metabolic crisis, physicians should monitor electrolyte levels. Electrolytes are certain salts and minerals that may be found in the body. Affected individuals should be monitored for normal levels of potassium, magnesium, and glucose.
During a metabolic crisis, treatment of heart rhythm abnormalities can differ depending on the specific type of ECG abnormality that is present. Because nearly all children in crisis have QT prolongation, all drugs that prolong the QT interval should be avoided. Magnesium should be used to maintain levels above 2 mg/dl
and if cardiac function is preserved, esmolol may be tried. However, arrhythmias degenerate rapidly and any child with premature ventricular contractions (PVCs) should be immediately transferred to an intensive care unit. Single PVCs can be treated with esmolol and magnesium but any higher grade arrhythmias or ventricular tachycardia appears to respond best to isoproterenol. Atrial pacing can also be used.
Recurrent ventricular tachycardia or torsade de pointes can be treated by cardioversion but will typically recur. As soon as ventricular tachycardia or torsade de pointes is seen, isoproterenol should be considered and quickly administered if possible. Cardiac dysfunction may limit the use of this drug. Cardioversion is a method of restoring heart rhythm to normal, either through electrical shock or with specific medications. Direct current cardioversion is a procedure in which a small electrical charge is delivered to the heart in order to “shock” it back to normal rhythm. Although at this time isoproterenol appears to be the most effective drug choice for ventricular tachycardia, death has occurred despite its use. Because researchers do not completely understand the underlying reason that arrhythmias occur in this disorder, the ideal treatments for heart rhythm problems is not known.
Individuals who have had ventricular arrhythmias may receive an implantable cardioverter defibrillator (ICD). These small devices are implanted under the skin of the chest and wires are passed down into the heart to monitor the heart rhythm. The device detects episodes of heart rhythm irregularity and delivers an electrical shock to restore normal heart rhythm. ICDs do not prevent the occurrence of torsade de pointes and thus acute arrhythmias need to be managed with antiarrhythmic medications. Because arrhythmias appear to only occur during metabolic crisis and because these medications can cause hypoglycemia, whether or not to take prophylactic or daily antiarrhythmic medications is unknown. Some individuals have undergone a cardiac sympathectomy, a surgical procedure in which certain nerves going to the heart are cut or clamped. Whether or not this is an effective treatment is not known. An ICD is a therapy that carries significant medical and psychological complications, especially in younger individuals, and should be undertaken only after detailed consultation with appropriate medical personnel experienced in the management of heart rhythm abnormalities and a careful consideration of the risks and benefits.
Hypothyroidism may be treated with a medication called levothyroxine. This medication replaces or provides more of the thyroid hormone that affected individuals are lacking. Seizures may be treated with anti-seizure medications called anti-convulsants or anti-epileptics.
Affected children may benefit from occupational, physical, and speech therapy. Additional medical, social, and/or vocational services including specialized learning programs may be necessary.
Information on current clinical trials is posted on the Internet at https://clinicaltrials.gov/. All studies receiving U.S. Government funding, and some supported by private industry, are posted on this government web site.
For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:
Toll-free: (800) 411-1222
TTY: (866) 411-1010
Email: [email protected]
Some current clinical trials also are posted on the following page on the NORD website:
For information about clinical trials sponsored by private sources, contact:
For information about clinical trials conducted in Europe, contact:
Ricci F, Scalco R, Mongini T, et al. Multi-system disorder and severe recurrent rhabdomyolysis due to TANGO2 mutations in a 3 year-old child. Neuromuscular Disorders. 2017;27:S207. https://www.nmd-journal.com/article/S0960-8966(17)30982-3/abstract
Lalani SR, Liu P, Rosenfeld JA, et al. Recurrent muscle weakness with rhabdomyolysis, metabolic crises, and cardiac arrhythmia due to bi-allelic TANGO2 mutations. Am J Hum Genet. 2016;98:347-357 . https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746334/
Kremer LS, Distelmaier F, Alhaddad B, et al. Bi-allelic truncating mutations in TANGO2 cause infancy-onset recurrent metabolic crises with encephalocardiomyopathy. Am J Hum Genet. 2016;98:358-362. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746337/
Elsayed EF, Reilly RF. Rhabdomyolysis: a review, with emphasis on the pediatric population. Pediatr Nephrol. 2010;25:7-18. https://www.ncbi.nlm.nih.gov/pubmed/19529963
Lalani SR, Graham B, Burrage L, et al. TANGO2-related metabolic encephalopathy and arrhythmias. 2018 Jan 25]. In: Pagon RA, Bird TD, Dolan CR, et al., GeneReviews. Internet. Seattle, WA: University of Washington, Seattle; 1993-. Available at: https://www.ncbi.nlm.nih.gov/books/NBK476443/ Accessed Sept. 6, 2018.
Genetic and Rare Disease Information Center. TANGO2-related metabolic encephalopathy and arrhythmias. March 19, 2018. Available at: https://rarediseases.info.nih.gov/diseases/13423/tango2-related-metabolic-encephalopathy-and-arrhythmias Accessed July 10, 2018.
McKusick VA., ed. Online Mendelian Inheritance in Man (OMIM). Baltimore. MD: The Johns Hopkins University; Entry No:616878; Last Update:08/08/2017. Available at: https://www.omim.org/entry/616878 Accessed July 10, 2018.
TANGO2 Research Foundation. About TANGO2. Available at: http://tango2research.org/about-tango2/ Accessed July 10, 2018.
Cardioversion. American Heart Association. September 2016. Available at: http://www.heart.org/ Accessed July 10, 2018.
The information in NORD’s Rare Disease Database is for educational purposes only and is not intended to replace the advice of a physician or other qualified medical professional.
The content of the website and databases of the National Organization for Rare Disorders (NORD) is copyrighted and may not be reproduced, copied, downloaded or disseminated, in any way, for any commercial or public purpose, without prior written authorization and approval from NORD. Individuals may print one hard copy of an individual disease for personal use, provided that content is unmodified and includes NORD’s copyright.
National Organization for Rare Disorders (NORD)
55 Kenosia Ave., Danbury CT 06810 • (203)744-0100